Regulation of central tolerance and Treg development by recirculating Treg
Regulation of central tolerance and Treg development by recirculating Treg
批准号:
10615598
负责人:
Michael Archibald Farrar
金额:
$38.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2027-04-30
关键词:
AdultAffectAgeAntigen-Presenting CellsAntigensAutoimmunityBackBiologicalCell CountCell DensityCellsCellular Indexing of Transcriptomes and Epitopes by SequencingClonal DeletionCytolysisDevelopmentDiseaseEffector CellEnsureEquilibriumFOXP3 geneGrowthHeterogeneityHomeostasisHumanImmuneImmune ToleranceImmune responseImmune systemImmunityImmunologic SurveillanceImpairmentInfectionLifeMaintenanceMediatingMusOrganOutputPerinatalPeripheralPlayPopulationProcessRegulationRegulatory T-LymphocyteRoleSelf ToleranceSiteSystemT cell receptor repertoire sequencingT-Cell DevelopmentT-cell diversityT-cell receptor repertoireTNFSF10 geneTNFSF6 geneTestingThymic epithelial cellThymus GlandTimeautoreactive T cellautoreactivitycentral tolerancecross reactivityeffector T cellexperimental studyimmunopathologyimmunoregulationmouse modelnovelpathogenperforinpreventthymocytetranscription factortranscriptome sequencingtranscriptomicstumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Effective cell-based immunity depends on two major systems: (i) the ability to generate a diverse TCR
repertoire capable of recognizing antigens from previously unencountered pathogens, and (ii) the ability to
discriminate between self- and non-self-antigens and prevent autoimmunity. Inappropriate balance between
these two systems causes a variety of disease states including ineffective tumor immune surveillance and poor
pathogen clearance due to gaps in the TCR repertoire, or the onset of autoimmunity and off target
immunopathology during infection. Autoimmunity can be curtailed by deleting autoreactive TCRs or diverting
them into the Treg lineage in the thymus. However, given the high degree of cross-reactivity of TCRs this
process cannot be truly efficient at removing all self-reactive TCRs as this would remove much of the potential
diversity of the conventional TCR repertoire, thereby impairing immunity to pathogens. Thus, a key biological
question is how thymic selection functions to balance protection against autoimmunity while providing
effective immunity against pathogens. We hypothesize that a unique population of thymic recirculating
Treg cells (RT-Treg) act as a rheostat to decrease the stringency of selection once peripheral Treg cell
tolerance is established, thereby allowing for a more diverse and pathogen-reactive conventional
immune system. This will be examined in two specific aims: Aim 1: Define RT-Treg heterogeneity and
functional consequences of RT-Treg accumulation. Aim 2: Identify the mechanisms by which RT-Treg cells affect
immune repertoires and mTEC numbers. The proposed experiments will elucidate the role that RT-Treg play in
governing the stringency of central tolerance, both promoting effector cell diversity and ensuring maintenance
of self-tolerance by Treg cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory T Cells in Alzheimer's Disease
-
批准号:10515396
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulation of central tolerance and Treg development by recirculating Treg
-
批准号:10363236
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulatory T Cells in Alzheimer's Disease
-
批准号:10685434
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function
-
批准号:10614429
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10059179
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10319979
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10550155
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function
-
批准号:10382260
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Development of Immune Tolerance
-
批准号:10338131
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2016
-
负责人:Michael Archibald Farrar
-
依托单位:
Development of Immune Tolerance
-
批准号:10573296
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2016
-
负责人:Michael Archibald Farrar
-
依托单位:
TNF Receptor Superfamily Signaling in Immune Tolerance
-
批准号:8894185
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:9063487
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:9262063
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:8686567
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8230503
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8307275
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8617815
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8843379
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8105994
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8677789
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
海外基金